Related Experiment Video
Updated: Jul 20, 2026
05:43
Protocol for Developing a Femur Osteotomy Model in Wistar Albino Rats
Published on: August 31, 2022
[Renal osteodystrophy: diagnostic-therapeutic approach].
1Centar za hemodijalizu, KCU Sarajevo. resickcs@bih.net.ba
Medicinski Arhiv
|September 2, 2006
Summary
Mineral and bone metabolism disturbances are common in chronic kidney disease (CKD), leading to secondary parathyroid hyperplasia and elevated parathyroid hormone (PTH). Careful monitoring of minerals, vitamin D, and PTH is crucial for managing CKD-related bone disease.
Area of Science:
- Nephrology
- Endocrinology
- Mineral and Bone Metabolism
Background:
- Chronic kidney disease (CKD) frequently causes mineral and bone metabolism disturbances.
- Secondary parathyroid hyperplasia and elevated parathyroid hormone (PTH) are nearly universal in CKD patients.
- Disordered mineral metabolism and bone disease begin early in CKD and progress with kidney function decline.
Purpose of the Study:
- To highlight the commonality of mineral and bone metabolism issues in CKD.
- To emphasize the progression of these disorders throughout CKD stages.
- To underscore the impact of therapeutic approaches on CKD-related bone disease.
Main Methods:
- Review of established knowledge on CKD-MBD.
- Analysis of the progression of mineral and bone disorders in CKD.
- Consideration of therapeutic influences on bone disease in CKD.
Main Results:
- Mineral and bone metabolism disturbances are a hallmark of CKD.
- Secondary hyperparathyroidism is a near-constant complication of CKD.
- Therapeutic interventions can modify the course of CKD-MBD.
Conclusions:
- CKD-related bone disease requires continuous monitoring of calcium, phosphorus, vitamin D, and PTH levels.
- Frequent evaluation of therapeutic strategies is essential for optimal patient care.
- Management of CKD-MBD necessitates a proactive and adaptive approach.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...